Suppr超能文献

在连续12次流产后,一名患者接受了免疫抑制治疗,并产下了一个健康的婴儿。

After 12 consecutive miscarriages, a patient received immunosuppressive treatment and delivered an intact baby.

作者信息

Nakagawa Koji, Kuroda Keiji, Sugiyama Rikikazu, Yamaguchi Koushi

机构信息

Division of Reproductive Medicine Sugiyama Clinic Tokyo Japan.

Department of Obstetrics and Gynecology Faculty of Medicine Juntendo University Tokyo Japan.

出版信息

Reprod Med Biol. 2017 Jun 21;16(3):297-301. doi: 10.1002/rmb2.12040. eCollection 2017 Jul.

Abstract

AIM

An immune etiology for idiopathic recurrent miscarriage is an important issue because a fetus is allogenetically different from the mother. Type 1 T helper (Th1) and Type 2 (Th2) cells have important functions in immune responses and there is a general agreement that pregnancy is associated with Th2 cell dominance. The purpose of this case report is to establish the effectiveness of an immunosuppressive treatment for a patient who had 11 consecutive miscarriages despite several treatments, such as anticoagulation, that showed elevated Th1/Th2 cell ratios.

METHODS

This patient visited our clinic following 11 consecutive miscarriages between 2009 and 2014 that occurred between 5 and 8 weeks' gestation. The Th1/Th2 cell ratio was evaluated after the 12th conception and she received an immunosuppressive treatment (tacrolimus; 1 mg/d).

RESULTS

The Th1/Th2 cell ratio was elevated after the 12th conception, but the patient miscarried, with a normal karyotype of chorionic villi despite the immunosuppressive treatment. After the 13th conception, she began receiving treatment with 2 mg/d of tacrolimus at 4 weeks' gestation, which was continued until delivery.

CONCLUSION

For recurrent miscarriage cases that show an elevated Th1/Th2 cell ratio after achieving pregnancy, immunosuppressive treatment with tacrolimus could be effective.

摘要

目的

由于胎儿与母亲存在异基因差异,特发性复发性流产的免疫病因是一个重要问题。1型辅助性T细胞(Th1)和2型辅助性T细胞(Th2)在免疫反应中具有重要功能,并且普遍认为妊娠与Th2细胞占优势有关。本病例报告的目的是确定免疫抑制治疗对一名患者的有效性,该患者尽管接受了多种治疗(如抗凝治疗),但仍连续发生11次流产,且Th1/Th2细胞比值升高。

方法

该患者在2009年至2014年间连续发生11次流产,均发生在妊娠5至8周之间,之后前来我院就诊。在第12次妊娠后评估Th1/Th2细胞比值,并给予免疫抑制治疗(他克莫司;1mg/d)。

结果

第12次妊娠后Th1/Th2细胞比值升高,但患者仍流产,尽管进行了免疫抑制治疗,绒毛膜绒毛的核型正常。第13次妊娠后,她在妊娠4周时开始接受2mg/d他克莫司治疗,并持续至分娩。

结论

对于妊娠后Th1/Th2细胞比值升高的复发性流产病例,他克莫司免疫抑制治疗可能有效。

相似文献

6
Changes in maternal peripheral T helper 1-type and T helper 2-type immunity during labor.
Tohoku J Exp Med. 2001 Jun;194(2):137-40. doi: 10.1620/tjem.194.137.

引用本文的文献

2
Tacrolimus treatment in women with repeated implantation failures.他克莫司治疗反复种植失败的女性。
Reprod Med Biol. 2024 Jan 9;23(1):e12558. doi: 10.1002/rmb2.12558. eCollection 2024 Jan-Dec.
3
The Diagnostics and Treatment of Recurrent Pregnancy Loss.复发性流产的诊断与治疗
J Clin Med. 2023 Jul 19;12(14):4768. doi: 10.3390/jcm12144768.
5
Recurrent implantation failure: A comprehensive summary from etiology to treatment.反复种植失败:从病因到治疗的全面总结。
Front Endocrinol (Lausanne). 2023 Jan 5;13:1061766. doi: 10.3389/fendo.2022.1061766. eCollection 2022.

本文引用的文献

3
How safe are anti-rheumatic drugs during pregnancy?怀孕期间使用抗风湿药物安全吗?
Curr Opin Pharmacol. 2013 Jun;13(3):470-5. doi: 10.1016/j.coph.2013.03.004. Epub 2013 Mar 20.
4
Tacrolimus in transplant rejection.他克莫司在移植排斥中的应用。
Expert Opin Pharmacother. 2013 Jan;14(1):115-22. doi: 10.1517/14656566.2013.751374. Epub 2012 Dec 10.
5
Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy.妊娠中的 Th1/Th2/Th17 与调节性 T 细胞范式。
Am J Reprod Immunol. 2010 Jun;63(6):601-10. doi: 10.1111/j.1600-0897.2010.00852.x. Epub 2010 Apr 23.
7
Trophoblast immune receptors in maternal-fetal tolerance.母胎耐受中的滋养层免疫受体
Immunol Invest. 2008;37(5):395-426. doi: 10.1080/08820130802206066.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验